Given that metformin induces metabolic stress, it is tempting to propose that the sensitivity of lung cancer cells to drugs such as metformin can be enhanced if CHTM1 is genetically or pharmacologically antagonized. This evidence concerns the gene CHCHD5 and lung carcinoma.